ESR1 and breast cancer: Although ER and PR were not included in the BBO-selected model, hormone therapy (an effective treatment options for patients with ER positive or PR positive breast cancer) could partially explain the beneficial effect of ER and PR positive case with hormone therapy in breast cancer overall survival.